Skip to main content
Top
Published in: Virology Journal 1/2011

Open Access 01-12-2011 | Research

Identification of novel conserved functional motifs across most Influenza A viral strains

Authors: Mahmoud ElHefnawi, Osama AlAidi, Nafisa Mohamed, Mona Kamar, Iman El-Azab, Suher Zada, Rania Siam

Published in: Virology Journal | Issue 1/2011

Login to get access

Abstract

Background

Influenza A virus poses a continuous threat to global public health. Design of novel universal drugs and vaccine requires a careful analysis of different strains of Influenza A viral genome from diverse hosts and subtypes. We performed a systematic in silico analysis of Influenza A viral segments of all available Influenza A viral strains and subtypes and grouped them based on host, subtype, and years isolated, and through multiple sequence alignments we extrapolated conserved regions, motifs, and accessible regions for functional mapping and annotation.

Results

Across all species and strains 87 highly conserved regions (conservation percentage > = 90%) and 19 functional motifs (conservation percentage = 100%) were found in PB2, PB1, PA, NP, M, and NS segments. The conservation percentage of these segments ranged between 94 - 98% in human strains (the most conserved), 85 - 93% in swine strains (the most variable), and 91 - 94% in avian strains. The most conserved segment was different in each host (PB1 for human strains, NS for avian strains, and M for swine strains). Target accessibility prediction yielded 324 accessible regions, with a single stranded probability > 0.5, of which 78 coincided with conserved regions. Some of the interesting annotations in these regions included sites for protein-protein interactions, the RNA binding groove, and the proton ion channel.

Conclusions

The influenza virus has evolved to adapt to its host through variations in the GC content and conservation percentage of the conserved regions. Nineteen universal conserved functional motifs were discovered, of which some were accessible regions with interesting biological functions. These regions will serve as a foundation for universal drug targets as well as universal vaccine design.
Appendix
Available only for authorised users
Literature
1.
go back to reference Li OT, Chan MC, Leung CS, Chan RW, Guan Y, Nicholls JM, Poon LL: Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation. PLoS One 2009, 4: e5658. 10.1371/journal.pone.0005658PubMedCentralCrossRefPubMed Li OT, Chan MC, Leung CS, Chan RW, Guan Y, Nicholls JM, Poon LL: Full factorial analysis of mammalian and avian influenza polymerase subunits suggests a role of an efficient polymerase for virus adaptation. PLoS One 2009, 4: e5658. 10.1371/journal.pone.0005658PubMedCentralCrossRefPubMed
2.
go back to reference Skehel J: An overview of influenza haemagglutinin and neuraminidase. Biologicals 2009, 37: 177-178. 10.1016/j.biologicals.2009.02.012CrossRefPubMed Skehel J: An overview of influenza haemagglutinin and neuraminidase. Biologicals 2009, 37: 177-178. 10.1016/j.biologicals.2009.02.012CrossRefPubMed
3.
go back to reference Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, Subbu V, Spiro DJ, Sitz J, Koo H, Bolotov P, et al.: Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 2005, 437: 1162-1166. 10.1038/nature04239CrossRefPubMed Ghedin E, Sengamalay NA, Shumway M, Zaborsky J, Feldblyum T, Subbu V, Spiro DJ, Sitz J, Koo H, Bolotov P, et al.: Large-scale sequencing of human influenza reveals the dynamic nature of viral genome evolution. Nature 2005, 437: 1162-1166. 10.1038/nature04239CrossRefPubMed
4.
go back to reference Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al.: Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325: 197-201. 10.1126/science.1176225PubMedCentralCrossRefPubMed Garten RJ, Davis CT, Russell CA, Shu B, Lindstrom S, Balish A, Sessions WM, Xu X, Skepner E, Deyde V, et al.: Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science 2009, 325: 197-201. 10.1126/science.1176225PubMedCentralCrossRefPubMed
5.
go back to reference Tamuri AU, Dos Reis M, Hay AJ, Goldstein RA: Identifying changes in selective constraints: host shifts in influenza. PLoS Comput Biol 2009, 5: e1000564. 10.1371/journal.pcbi.1000564PubMedCentralCrossRefPubMed Tamuri AU, Dos Reis M, Hay AJ, Goldstein RA: Identifying changes in selective constraints: host shifts in influenza. PLoS Comput Biol 2009, 5: e1000564. 10.1371/journal.pcbi.1000564PubMedCentralCrossRefPubMed
6.
go back to reference Schroeder SJ: Advances in RNA structure prediction from sequence: new tools for generating hypotheses about viral RNA structure-function relationships. J Virol 2009, 83: 6326-6334. 10.1128/JVI.00251-09PubMedCentralCrossRefPubMed Schroeder SJ: Advances in RNA structure prediction from sequence: new tools for generating hypotheses about viral RNA structure-function relationships. J Virol 2009, 83: 6326-6334. 10.1128/JVI.00251-09PubMedCentralCrossRefPubMed
7.
go back to reference Elhefnawi MM, Youssif AA, Ghalwash AZ, Behaidy WH: An Integrated Methodology for Mining Promiscuous Proteins: A Case Study of an Integrative Bioinformatics Approach for Hepatitis C Virus Non-structural 5a Protein. Adv Exp Med Biol 680: 299-305. full_text Elhefnawi MM, Youssif AA, Ghalwash AZ, Behaidy WH: An Integrated Methodology for Mining Promiscuous Proteins: A Case Study of an Integrative Bioinformatics Approach for Hepatitis C Virus Non-structural 5a Protein. Adv Exp Med Biol 680: 299-305. full_text
8.
go back to reference Sirskyj D, Diaz-Mitoma F, Golshani A, Kumar A, Azizi A: Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses. Immunol Cell Biol 2011,89(1):81-9. 10.1038/icb.2010.65CrossRefPubMed Sirskyj D, Diaz-Mitoma F, Golshani A, Kumar A, Azizi A: Innovative bioinformatic approaches for developing peptide-based vaccines against hypervariable viruses. Immunol Cell Biol 2011,89(1):81-9. 10.1038/icb.2010.65CrossRefPubMed
9.
go back to reference ElHefnawi MM, Zada S, El-Azab IA: Prediction of prognostic biomarkers for Interferon-based therapy to Hepatitis C Virus patients: a metaanalysis of the NS5A protein in subtypes 1a, 1b, and 3a. Virol J 7: 130. 10.1186/1743-422X-7-130 ElHefnawi MM, Zada S, El-Azab IA: Prediction of prognostic biomarkers for Interferon-based therapy to Hepatitis C Virus patients: a metaanalysis of the NS5A protein in subtypes 1a, 1b, and 3a. Virol J 7: 130. 10.1186/1743-422X-7-130
10.
go back to reference Yan Q: Bioinformatics databases and tools in virology research: an overview. In Silico Biol 2008, 8: 71-85.PubMed Yan Q: Bioinformatics databases and tools in virology research: an overview. In Silico Biol 2008, 8: 71-85.PubMed
11.
go back to reference Fischer HP: Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Biotechnol Annu Rev 2005, 11: 1-68. full_textCrossRefPubMed Fischer HP: Towards quantitative biology: integration of biological information to elucidate disease pathways and to guide drug discovery. Biotechnol Annu Rev 2005, 11: 1-68. full_textCrossRefPubMed
12.
go back to reference Orth AP, Batalov S, Perrone M, Chanda SK: The promise of genomics to identify novel therapeutic targets. Expert Opin Ther Targets 2004, 8: 587-596. 10.1517/14728222.8.6.587CrossRefPubMed Orth AP, Batalov S, Perrone M, Chanda SK: The promise of genomics to identify novel therapeutic targets. Expert Opin Ther Targets 2004, 8: 587-596. 10.1517/14728222.8.6.587CrossRefPubMed
13.
go back to reference Yin PD, Das D, Mitsuya H: Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance. Cell Mol Life Sci 2006, 63: 1706-1724. 10.1007/s00018-006-6009-7CrossRefPubMed Yin PD, Das D, Mitsuya H: Overcoming HIV drug resistance through rational drug design based on molecular, biochemical, and structural profiles of HIV resistance. Cell Mol Life Sci 2006, 63: 1706-1724. 10.1007/s00018-006-6009-7CrossRefPubMed
14.
go back to reference Mitrasinovic PM: Advances in the structure-based design of the influenza A neuraminidase inhibitors. Curr Drug Targets 11: 315-326. 10.2174/138945010790711932 Mitrasinovic PM: Advances in the structure-based design of the influenza A neuraminidase inhibitors. Curr Drug Targets 11: 315-326. 10.2174/138945010790711932
15.
go back to reference Khan AM, Miotto O, Nascimento EJ, Srinivasan KN, Heiny AT, Zhang GL, Marques ET, Tan TW, Brusic V, Salmon J, August JT: Conservation and variability of dengue virus proteins: implications for vaccine design. PLoS Negl Trop Dis 2008, 2: e272. 10.1371/journal.pntd.0000272PubMedCentralCrossRefPubMed Khan AM, Miotto O, Nascimento EJ, Srinivasan KN, Heiny AT, Zhang GL, Marques ET, Tan TW, Brusic V, Salmon J, August JT: Conservation and variability of dengue virus proteins: implications for vaccine design. PLoS Negl Trop Dis 2008, 2: e272. 10.1371/journal.pntd.0000272PubMedCentralCrossRefPubMed
16.
go back to reference Ahn I, Son HS: The current trend of avian influenza viruses in bioinformatics research. J Prev Med Public Health 2007, 40: 185-190. 10.3961/jpmph.2007.40.2.185CrossRefPubMed Ahn I, Son HS: The current trend of avian influenza viruses in bioinformatics research. J Prev Med Public Health 2007, 40: 185-190. 10.3961/jpmph.2007.40.2.185CrossRefPubMed
17.
go back to reference Gendoo DM, El-Hefnawi MM, Werner M, Siam R: Correlating novel variable and conserved motifs in the Hemagglutinin protein with significant biological functions. Virol J 2008, 5: 91. 10.1186/1743-422X-5-91PubMedCentralCrossRefPubMed Gendoo DM, El-Hefnawi MM, Werner M, Siam R: Correlating novel variable and conserved motifs in the Hemagglutinin protein with significant biological functions. Virol J 2008, 5: 91. 10.1186/1743-422X-5-91PubMedCentralCrossRefPubMed
18.
go back to reference Bush RM, Fitch WM, Bender CA, Cox NJ: Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol 1999, 16: 1457-1465.CrossRefPubMed Bush RM, Fitch WM, Bender CA, Cox NJ: Positive selection on the H3 hemagglutinin gene of human influenza virus A. Mol Biol Evol 1999, 16: 1457-1465.CrossRefPubMed
19.
go back to reference Du X, Wang Z, Wu A, Song L, Cao Y, Hang H, Jiang T: Networks of genomic co-occurrence capture characteristics of human influenza A (H3N2) evolution. Genome Res 2008, 18: 178-187. 10.1101/gr.6969007PubMedCentralCrossRefPubMed Du X, Wang Z, Wu A, Song L, Cao Y, Hang H, Jiang T: Networks of genomic co-occurrence capture characteristics of human influenza A (H3N2) evolution. Genome Res 2008, 18: 178-187. 10.1101/gr.6969007PubMedCentralCrossRefPubMed
20.
go back to reference Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, Eisen HN, Chen J: RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 2003, 100: 2718-2723. 10.1073/pnas.0437841100PubMedCentralCrossRefPubMed Ge Q, McManus MT, Nguyen T, Shen CH, Sharp PA, Eisen HN, Chen J: RNA interference of influenza virus production by directly targeting mRNA for degradation and indirectly inhibiting all viral RNA transcription. Proc Natl Acad Sci USA 2003, 100: 2718-2723. 10.1073/pnas.0437841100PubMedCentralCrossRefPubMed
21.
go back to reference Furuse Y, Suzuki A, Kamigaki T, Oshitani H: Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virol J 2009, 6: 67. 10.1186/1743-422X-6-67PubMedCentralCrossRefPubMed Furuse Y, Suzuki A, Kamigaki T, Oshitani H: Evolution of the M gene of the influenza A virus in different host species: large-scale sequence analysis. Virol J 2009, 6: 67. 10.1186/1743-422X-6-67PubMedCentralCrossRefPubMed
22.
go back to reference Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D: The influenza virus resource at the National Center for Biotechnology Information. J Virol 2008, 82: 596-601. 10.1128/JVI.02005-07PubMedCentralCrossRefPubMed Bao Y, Bolotov P, Dernovoy D, Kiryutin B, Zaslavsky L, Tatusova T, Ostell J, Lipman D: The influenza virus resource at the National Center for Biotechnology Information. J Virol 2008, 82: 596-601. 10.1128/JVI.02005-07PubMedCentralCrossRefPubMed
23.
24.
go back to reference Marsh GA, Rabadan R, Levine AJ, Palese P: Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. J Virol 2008, 82: 2295-2304. 10.1128/JVI.02267-07PubMedCentralCrossRefPubMed Marsh GA, Rabadan R, Levine AJ, Palese P: Highly conserved regions of influenza a virus polymerase gene segments are critical for efficient viral RNA packaging. J Virol 2008, 82: 2295-2304. 10.1128/JVI.02267-07PubMedCentralCrossRefPubMed
25.
go back to reference Obayashi E, Yoshida H, Kawai F, Shibayama N, Kawaguchi A, Nagata K, Tame JR, Park SY: The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature 2008, 454: 1127-1131. 10.1038/nature07225CrossRefPubMed Obayashi E, Yoshida H, Kawai F, Shibayama N, Kawaguchi A, Nagata K, Tame JR, Park SY: The structural basis for an essential subunit interaction in influenza virus RNA polymerase. Nature 2008, 454: 1127-1131. 10.1038/nature07225CrossRefPubMed
27.
28.
go back to reference El Hefnawi MM, El Behaidy WH, Youssif AA, Ghalwash AZ, El Housseiny LA, Zada S: Natural genetic engineering of hepatitis C virus NS5A for immune system counterattack. Ann N Y Acad Sci 2009, 1178: 173-185. 10.1111/j.1749-6632.2009.05003.xCrossRefPubMed El Hefnawi MM, El Behaidy WH, Youssif AA, Ghalwash AZ, El Housseiny LA, Zada S: Natural genetic engineering of hepatitis C virus NS5A for immune system counterattack. Ann N Y Acad Sci 2009, 1178: 173-185. 10.1111/j.1749-6632.2009.05003.xCrossRefPubMed
30.
go back to reference Rice P, Longden I, Bleasby A: EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000, 16: 276-277. 10.1016/S0168-9525(00)02024-2CrossRefPubMed Rice P, Longden I, Bleasby A: EMBOSS: the European Molecular Biology Open Software Suite. Trends Genet 2000, 16: 276-277. 10.1016/S0168-9525(00)02024-2CrossRefPubMed
31.
go back to reference Perez-Bercoff A, Koch J, Burglin TR: LogoBar: bar graph visualization of protein logos with gaps. Bioinformatics 2006, 22: 112-114. 10.1093/bioinformatics/bti761CrossRefPubMed Perez-Bercoff A, Koch J, Burglin TR: LogoBar: bar graph visualization of protein logos with gaps. Bioinformatics 2006, 22: 112-114. 10.1093/bioinformatics/bti761CrossRefPubMed
32.
go back to reference Field D, Tiwari B, Booth T, Houten S, Swan D, Bertrand N, Thurston M: Open software for biologists: from famine to feast. Nat Biotechnol 2006, 24: 801-803. 10.1038/nbt0706-801CrossRefPubMed Field D, Tiwari B, Booth T, Houten S, Swan D, Bertrand N, Thurston M: Open software for biologists: from famine to feast. Nat Biotechnol 2006, 24: 801-803. 10.1038/nbt0706-801CrossRefPubMed
33.
go back to reference Hall TA: BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999, 41: 95-98. Hall TA: BioEdit: A user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT. Nucleic Acids Symp Ser 1999, 41: 95-98.
35.
go back to reference Ding Y, Chan CY, Lawrence CE: Sfold web server for statistical folding and rational design of nucleic acids. Nucleic Acids Res 2004, 32: W135-141. 10.1093/nar/gkh449PubMedCentralCrossRefPubMed Ding Y, Chan CY, Lawrence CE: Sfold web server for statistical folding and rational design of nucleic acids. Nucleic Acids Res 2004, 32: W135-141. 10.1093/nar/gkh449PubMedCentralCrossRefPubMed
Metadata
Title
Identification of novel conserved functional motifs across most Influenza A viral strains
Authors
Mahmoud ElHefnawi
Osama AlAidi
Nafisa Mohamed
Mona Kamar
Iman El-Azab
Suher Zada
Rania Siam
Publication date
01-12-2011
Publisher
BioMed Central
Published in
Virology Journal / Issue 1/2011
Electronic ISSN: 1743-422X
DOI
https://doi.org/10.1186/1743-422X-8-44

Other articles of this Issue 1/2011

Virology Journal 1/2011 Go to the issue
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.